UPDATE: Brookline Capital Markets Starts Verrica Pharmaceuticals (VRCA) at Buy
Tweet Send to a Friend
(Updated - March 9, 2022 4:48 PM EST)
Brookline Capital Markets analyst Kemp Dolliver initiates coverage on Verrica Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Brookline Capital Markets analyst Kemp Dolliver initiates coverage on Verrica Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
